Cytologic risk stratification of medullary thyroid carcinoma: Does it make the grade?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cytologic risk stratification of medullary thyroid carcinoma: Does it make the grade?

Published:2024-02-02 Issue:4 Volume:132 Page:209-211
ISSN:1934-662X
Container-title:Cancer Cytopathology
language:en
Short-container-title:Cancer Cytopathology

Author:

Nishino Michiya¹^ORCID

Affiliation:

1. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston Massachusetts USA

Abstract

Recent efforts to develop a histologic grading system for medullary thyroid carcinoma is gaining broad acceptance. How well do these grading parameters translate to cytology specimens?

Publisher

Wiley

Reference15 articles.

1. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Thyroid Carcinoma. Version 4.2023.National Comprehensive Cancer Network. Accessed August 16 2023.https://www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf

2. A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis

3. International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thyroid Nodules and Biopsy;Hypothyroidism - Causes, Screening and Therapeutic Approaches [Working Title];2024-06-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP